1. |
Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica[J]. Lancet Neurol, 2007, 6(9): 805-815. DOI: 10.1016/S1474-4422(07)70216-8.
|
2. |
魏世辉, 杨沫, 吴卫平. 视神经脊髓炎谱系疾病的流行病学研究[J]. 中华眼科杂志, 2019, 55(3): 234-240. DOI: 10.3760/cma.j.issn.0412-4081.2019.03.017.Wei SH, Yang M, Wu WP. Epidemiological study of neuromyelitis optica spectrum disorders[J]. Chin J Ophthalmol, 2019, 55(3): 234-240. DOI: 10.3760/cma.j.issn.0412-4081.2019.03.017.
|
3. |
Hyun JW, Jeong IH, Joung A, et al. Evaluation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorder[J]. Neurology, 2016, 86(19): 1772-1779. DOI: 10.1212/WNL.0000000000002655.
|
4. |
ZhangBao J, Zhou L, Li X, et al. The clinical characteristics of AQP4 antibody positive NMO/SD in a large cohort of Chinese Han patients[J]. J Neuroimmunol, 2017, 302: 49-55. DOI: 10.1016/j.jneuroim.2016.11.010.
|
5. |
Merle H, Olindo S, Bonnan M, et al. Natural history of the visual impairment of relapsing neuromyelitis optica[J]. Ophthalmology, 2007, 114(4): 810-815. DOI: 10.1016/j.ophtha.2006.06.060.
|
6. |
王梅子, 王淑然, 王丽娜, 等. OCT对多发性硬化与视神经脊髓炎谱系疾病患者视功能损伤的评价[J]. 国际眼科杂志, 2016, 16(7): 1253-1257. DOI: 10.3980/j.issn.1672-5123.2016.7.12.Wang MZ, Wang SR, Wang LN, et al. Assessment of the damage to visual function by optical coherence tomography in patients with multiple sclerosis or neuromyelitis optica spectrum disorders[J]. Int Eye Sci, 2016, 16(7): 1253-1257. DOI: 10.3980/j.issn.1672-5123.2016.7.12.
|
7. |
van Pelt ED, Wong YY, Ketelslegers IA, et al. Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4‐IgG versus MOG‐IgG seropositive cases in the Netherlands[J]. Eur J Neurol, 2016, 23(3): 580-587. DOI: 10.1111/ene.12898.
|
8. |
Peng CX, Li HY, Wang W, et al. Retinal segmented layers with strong aquaporin-4 expression suffered more injuries in neuromyelitis optica spectrum disorders compared with optic neuritis with aquaporin-4 antibody seronegativity detected by optical coherence tomography[J]. Br J Ophthalmol, 2017, 101(8): 1032-1037. DOI: 10.1136/bjophthalmol-2016-309412.
|
9. |
Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders[J]. Neurology, 2015, 85(2): 177-189. DOI: 10.1212/WNL.0000000000001729.
|
10. |
Huang Y, Zhou L, ZhangBao J, et al. Peripapillary and parafoveal vascular network assessment by optical coherence tomography angiography in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders[J]. Br J Ophthalmol, 2019, 103(6): 789-796. DOI: 10.1136/bjophthalmol-2018-312231.
|
11. |
Outteryck O, Majed B, Defoort-Dhellemmes S, et al. A comparative optical coherence tomography study in neuromyelitis optica spectrum disorder and multiple sclerosis[J]. Mult Scler, 2015, 21(14): 1781-1793. DOI: 10.1177/1352458515578888.
|
12. |
Shindler KS, Ventura E, Dutt M, et al. Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis[J]. Exp Eye Res, 2008, 87(3): 208-213. DOI: 10.1016/j.exer.2008.05.017.
|
13. |
Kwapong WR, Peng C, He Z, et al. Altered macular microvasculature in neuromyelitis optica spectrum disorders[J]. Am J Ophthalmol, 2018, 192: 47-55. DOI: 10.1016/j.ajo.2018.04.026.
|
14. |
Li B, Freeman RD. Neurometabolic coupling between neural activity, glucose, and lactate in activated visual cortex[J]. J Neurochem, 2015, 135(4): 742-754. DOI: 10.1111/jnc.13143.
|
15. |
Feucht N, Maier M, Lepennetier G, et al. Optical coherence tomography angiography indicates associations of the retinal vascular network and disease activity in multiple sclerosis[J]. Mult Scler, 2019, 25(2): 224-234. DOI: 10.1177/1352458517750009.
|
16. |
Dallorto L, Lavia C, Jeannerot AL, et al. Retinal microvasculature in pituitary adenoma patients: is optical coherence tomography angiography useful?[J/OL]. Acta Ophthalmol, 2020, 2020: E1[2019-12-06]. https://pubmed.ncbi.nlm.nih.gov/31808290/. DOI: 10.1111/aos.14322.[published online ahead of print].
|
17. |
Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis[J]. Lancet, 2004, 364(9451): 2106-2112. DOI: 10.1016/S0140-6736(04)17551-X.
|
18. |
Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel[J]. J Exp Med, 2005, 202(4): 473-477. DOI: 10.1084/jem.20050304.
|
19. |
Mulligan SJ, MacVicar BA. Calcium transients in astrocyte endfeet cause cerebrovascular constrictions[J]. Nature, 2004, 431(7005): 195-199. DOI: 10.1038/nature02827.
|
20. |
Iandiev I, Pannicke T, Biedermann B, et al. Ischemia-reperfusion alters the immunolocalization of glial aquaporins in rat retina[J]. Neurosci Lett, 2006, 408(2): 108-112. DOI: 10.1016/j.neulet.2006.08.084.
|
21. |
Bennett WM. Renal effects of cyclosporine[J]. J Am Acad Dermatol, 1990, 23(6 Pt 2): 1280-1287. DOI: 10.1016/0190-9622(90)70355-l.
|
22. |
Myers BD, Ross J, Newton L, et al. Cyclosporine-associated chronic nephropathy[J]. N Engl J Med, 1984, 311(11): 699-705. DOI: 10.1056/NEJM198409133111103.
|
23. |
Myers BD, Sibley R, Newton L, et al. The long-term course of cyclosporine-associated chronic nephropathy[J]. Kidney International, 1988, 33(2): 590-600. DOI: 10.1038/ki.1988.38.
|
24. |
Pache F, Zimmermann H, Mikolajczak J, et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients[J/OL]. J Neuroinflammation, 2016, 13(1): 282[2016-11-01]. https://pubmed.ncbi.nlm.nih.gov/27802824/. DOI: 10.1186/s12974-016-0720-6.
|
25. |
Sotirchos ES, Filippatou A, Fitzgerald KC, et al. Aquaporin-4 IgG seropositivity is associated with worse visual outcomes after optic neuritis than MOG-IgG seropositivity and multiple sclerosis, independent of macular ganglion cell layer thinning[J]. Mult Scler, 2020, 26(11): 1360-1371. DOI: 10.1177/1352458519864928.
|
26. |
Costello F, Hodge W, Pan YI, et al. Using retinal architecture to help characterize multiple sclerosis patients[J]. Can J Ophthalmol, 2010, 45(5): 520-526. DOI: 10.3129/i10-063.
|
27. |
Hokari M, Yokoseki A, Arakawa M, et al. Clinicopathological features in anterior visual pathway in neuromyelitis optica[J]. Ann Neurol, 2016, 79(4): 605-624. DOI: 10.1002/ana.24608.
|
28. |
Pannicke T, Wurm A, Iandiev I, et al. Deletion of aquaporin-4 renders retinal glial cells more susceptible to osmotic stress[J]. J Neurosci Res, 2010, 88(13): 2877-2888. DOI: 10.1002/jnr.22437.
|
29. |
Shen W, Fruttiger M, Zhu L, et al. Conditional Müller cell ablation causes independent neuronal and vascular pathologies in a novel transgenic model[J]. J Neurosci, 2012, 32(45): 15715-15727. DOI: 10.1523/JNEUROSCI.2841-12.2012.
|
30. |
Merle H, Olindo SP, Donnio AL, et al. Retinal peripapillary nerve fiber layer thickness in neuromyelitis optica[J]. Invest Ophthalmol Vis Sci, 2008, 49(10): 4412-4417. DOI: 10.1167/iovs.08-1815.
|
31. |
Fisher JB, Jacobs DA, Markowitz CE, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis[J]. Ophthalmology, 2006, 113(2): 324-332. DOI: 10.1016/j.ophtha.2005.10.040.
|